Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) is an endogenous agent
that induces apoptosis selectively in cancer cells. Soluble or expressed in immune cells …

TRAIL is a promising candidate for cancer therapeutics that preferentially induces apoptosis
in cancer cells. The combined treatment flavonoids with TRAIL might be promising as a …

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is considered as the most
promising anticancer agent in the TNF superfamily because of its selective cytotoxicity …

Prostate cancer represents an ideal disease for chemopreventive intervention. Genistein,
daidzein and equol, the predominant soy isoflavones, have been reported to lower the risk …

Isoflavones are a class of bioactive polyphenols with cancer chemopreventive properties.
TRAIL (tumor necrosis factor-related apoptosis-inducing ligand) is a naturally occurring …

Naturally occurring phenolic compounds have been shown to sensitize prostate cancer cells
to tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis …

TRAIL can induce apoptosis in some cancer cells and is an immune effector in the
surveillance and elimination of developing tumors. Yes, some cancers are resistant to …

TNF‐related apoptosis‐inducing ligand (TRAIL) is a promising cancer therapy that
preferentially induces apoptosis in cancer cells. However, many neoplasms are resistant to …

Background We have recently shown that curcumin (a diferuloylmethane) inhibits growth
and induces apoptosis, and also demonstrated that TRAIL induces apoptosis by binding to …

Aim: TNF (tumor necrosis factor)-related apoptosis-inducing ligand (TRAIL), is a selective
killer of tumor cells, although its potential is limited by the development of resistance. In this …